PHILADELPHIA, May 9, 2023 /PRNewswire/ — Interius BioTherapeutics, a preclinical stage gene therapy company developing novel methods for…
PHILADELPHIA, May 9, 2023 /PRNewswire/ — Interius BioTherapeutics, a preclinical stage gene therapy company developing novel methods for…
Philadelphia, PA – April 27, 2023 – Interius BioTherapeutics, a preclinical stage gene therapy company…
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
Company also celebrates “Deal of the Year” awarded by The Penn Center for Innovation PHILADELPHIA,…